Atlas Trials

Dan Zandberg

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Dan Zandberg

RecordFirmDate
Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCC (NCT06052839)Dan Zandberg2023-10-03
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies (NCT04114136)Dan Zandberg2020-09-14
HPV-16 Vaccination and Pembrolizumab Plus Cisplatin for "Intermediate Risk" HPV-16-associated Head and Neck Squamous Cell Carcinoma (NCT04369937)Dan Zandberg2020-07-06
Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab (NCT04074967)Dan Zandberg2020-06-11
Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy (NCT04326257)Dan Zandberg2020-05-14
Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer (NCT04080804)Dan Zandberg2019-12-20
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors (NCT04157985)Dan Zandberg2019-11-15

Track Dan Zandberg automatically

Every clearance here is in the API, with alerts when new ones post.